ICMR licenses nine breakthrough health technologies to industry partners including Biological E, Zydus
New Delhi: In a landmark moment for India’s healthcare innovation ecosystem, the Indian Council of Medical Research (ICMR) licensed nine cutting-edge technologies to industry partners under its Medical Innovations– Patent Mitra initiative, at Bharat Mandapam.
The Technologies licensed during the ceremony include a multistage Malaria Vaccine, which was granted to Indian Immunologicals Limited, Techinvention Lifecare Private Limited, Panacea Biotec Limited, Biological E Limited, and Zydus Lifesciences. Diagnostic ELISA kits for the detection of IgM antibodies against Japanese Encephalitis, and Dengue viruses, were licensed to Diatek Healthcare Private Limited and Medsource Ozone Biomedicals Private Limited, while Diagnostic ELISA kits for the detection of IgM antibodies against Chikungunya virus, were licensed to Diatek Healthcare Private Limited; Medsource Ozone Biomedicals Private Limited; and Matrix Labs Private Limited.
The AFuPEPLISA immunodiagnostic kit for detecting antibodies to Aspergillus fumigatus in patient sera, was licensed to Medsource Ozone Biomedicals Private Limited. SmartQR Technologies Private Limited received licenses for two colorimetric assays—one for rapid detection of Monkeypox virus and another RT-LAMP assay for Nipah virus. Biological E Limited was also licensed two novel vaccines: a glycoconjugate Salmonella vaccine and an oral Shigella vaccine based on Multi-Serotype Outer Membrane Vesicles (MOMVs).
During the inaugural session of the India MedTech Expo 2025, the ceremony resulted in 17 licensing deals for innovations developed by various ICMR institutes in the areas of infectious disease diagnostics, immunodiagnostics, and vaccine development.
Senior officials from ICMR congratulated the scientists, innovators, and industry partners, noting that the initiative exemplifies how public research and private enterprise can work together to deliver high-quality, affordable, and homegrown medical innovations for every citizen.
The Medical Innovations – Patent Mitra initiative, launched earlier this year on 8 March 2025 during the International Symposium on Health Technology Assessment (ISHTA 2025), was developed under the guidance of NITI Aayog. It is a collaborative effort involving the Department of Pharmaceuticals (DoP) and supported by the Department for Promotion of Industry and Internal Trade (DPIIT). The initiative aims to streamline the patenting process, strengthen intellectual property support, and accelerate the transfer of publicly funded innovations to industry for large-scale implementation.
This initiative ensures that life-saving tools developed through public research are available to communities across India. The manufacturing strength and distribution networks of industry partners will be instrumental in expanding the reach and impact of these technologies. This public-private partnership is a powerful catalyst for advancing India’s healthcare goals and plays a vital role in the journey toward achieving the vision of Viksit Bharat by 2047.
The India MedTech Expo 2025, taking place from 4th to 6th September 2025, provides a dynamic platform to showcase India’s growing leadership in the health and medical technology sectors, bringing together all the stakeholders, such as PLI participants, start-ups, MSMEs, innovative entrepreneurs, R&D facilities, incubators, as well as public and private hospitals.
Dr. Rajiv Bahl, Secretary, Department of Health Research & Director General, ICMR, senior officers of the Ministry and industry partners were also present at the event.
Also Read: India laying foundations to emerge as global MedTech hub, says Shri Amit Agrawal
